The role of intravenous iron in anemia management and transfusion avoidance. (mở cửa sổ mới)

Auerbach M, Goodnough LT, Picard D, Maniatis A.

Nguồn‎: Transfusion 2008;48(5):988-1000.

Mã bài‎: PubMed 18346021

DOI‎: 10.1111/j.1537-2995.2007.01633.x

https://www.ncbi.nlm.nih.gov/pubmed/18346021 (mở cửa sổ mới)

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. (mở cửa sổ mới)

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

Nguồn‎: BJU Int 2011;108(10):1582-7.

Mã bài‎: PubMed 21443653

DOI‎: 10.1111/j.1464-410X.2011.10173.x

https://www.ncbi.nlm.nih.gov/pubmed/21443653 (mở cửa sổ mới)

The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortality. (mở cửa sổ mới)

Lepor H, Lipkin M, Slova D.

Nguồn‎: Urology 2010;75(6):1424-8.

Mã bài‎: PubMed 20513505

DOI‎: 10.1016/j.urology.2009.06.095

https://www.ncbi.nlm.nih.gov/pubmed/20513505 (mở cửa sổ mới)

Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy. (mở cửa sổ mới)

Nieder AM, Rosenblum N, Lepor H.

Nguồn‎: Urology 2001;57(4):737-41.

Mã bài‎: PubMed 11306393

https://www.ncbi.nlm.nih.gov/pubmed/11306393 (mở cửa sổ mới)